retatrutide phase 3 2025 triple agonist glp-1 gip glucagon ✨ Retatrutide: The Next Evolution in Weight Loss Medications ✨ You may be hearing the informal term “GLP-3” — but what does that actually mean? is a new triple-agonist medication that Retatrutide is a triple-agonist drug

BPC-157: 0.5 mg daily (or 0.25 mg twice daily) TB-500: 2-2.5 mg twice weekly (loading phase) Duration: 4-6 weeks loading, then 2-4 weeks maintenance Maintenance TB-500: 2 mg once weekly Administration: Use separate syringes

The amount of retatrutide you should take during this first week should remain at your chosen starting dose regardless of whether you feel effects

Lipo injections require a prescription

After exercise, the body is more responsive to nutrients a well-balanced meal with protein, fiber, and healthy fats during this post-workout window may further stimulate GLP-1 and support appetite regulation and metabolic health

You can really feel the thermogenic effect

Keep the capsules in a cool and dry place, out of reach of children